QQ客服 官方微博 反馈留言

	Synergistic Activity of an Antimetabolite Drug and Tyrosine Kinase Inhibitors against Breast Cancer Cells
	Wu, Yushan; Zhang, Dongxing; Wu, Baofan; Quan, Yuan; Liu, Dongwu; Li, Yanyan; Zhang, Xiuzhen
刊名	CHEMICAL & PHARMACEUTICAL BULLETIN
	2017
卷号	65期号:8页码:768-775
关键词	cladribine gefitinib dasatinib breast cancer combination therapy
DOI	10.1248/cpb.c17-00261
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4592833
专题	山东大学
作者单位	1.Shandong Univ Technol, Sch Life Sci, 12 Zhangzhou Rd, Zibo 255049, Peoples R China. 2.[Wu,
推荐引用方式 GB/T 7714	Wu, Yushan,Zhang, Dongxing,Wu, Baofan,et al. Synergistic Activity of an Antimetabolite Drug and Tyrosine Kinase Inhibitors against Breast Cancer Cells[J]. CHEMICAL & PHARMACEUTICAL BULLETIN,2017,65(8):768-775.
APA	Wu, Yushan.,Zhang, Dongxing.,Wu, Baofan.,Quan, Yuan.,Liu, Dongwu.,...&Zhang, Xiuzhen.(2017).Synergistic Activity of an Antimetabolite Drug and Tyrosine Kinase Inhibitors against Breast Cancer Cells.CHEMICAL & PHARMACEUTICAL BULLETIN,65(8),768-775.
MLA	Wu, Yushan,et al."Synergistic Activity of an Antimetabolite Drug and Tyrosine Kinase Inhibitors against Breast Cancer Cells".CHEMICAL & PHARMACEUTICAL BULLETIN 65.8(2017):768-775.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。